Maureen Lynn Spitzer, MD Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 15 Chesterfield Road, Suite 212, East Lyme, CT 06333 Phone: 860-739-5557 Fax: 860-691-1980 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that it has completed the acquisition of ratiopharm, Germany's second largest generics producer. Following the acquisition, Teva will be the number one generic company in Europe, holding the leading market position in ten countries, as well as ranking in the top three in seven additional countries. In addition, the transaction will significantly increase Teva's sales in Canada.
Oxford University Press is pleased to announce its new partnership with the Congress of Neurological Surgeons. Beginning in January 2017, OUP will publish Neurosurgery and Operative Neurosurgery.
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
A new method of using adult stem cells as a model for the hereditary condition Gaucher disease could help accelerate the discovery of new, more effective therapies for this and other conditions such as Parkinson's, according to new research from the University of Maryland School of Medicine.
› Verified 1 days ago